Zurich Cantonal Bank’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Hold |
0
| – | – | – | 2642 |
|
|
2025
Q4 | – | Sell |
-56
| Closed | -$11.6K | – | 2631 |
|
|
2025
Q3 | $11.1K | Sell |
56
-27
| -33% | -$5.04K | ﹤0.01% | 2495 |
|
|
2025
Q2 | $14.3K | Sell |
83
-14
| -14% | -$2.28K | ﹤0.01% | 2498 |
|
|
2025
Q1 | $15.1K | Sell |
97
-16
| -14% | -$2.29K | ﹤0.01% | 2568 |
|
|
2024
Q4 | $15.6K | Sell |
113
-26
| -19% | -$3.42K | ﹤0.01% | 2598 |
|
|
2024
Q3 | $20.8K | Hold |
139
| – | – | ﹤0.01% | 2597 |
|
|
2024
Q2 | $19K | Sell |
139
-3
| -2% | -$408 | ﹤0.01% | 2592 |
|
|
2024
Q1 | $21.5K | Buy |
142
+32
| +29% | +$4.57K | ﹤0.01% | 2623 |
|
|
2023
Q4 | $13.9K | Sell |
110
-14
| -11% | -$1.4K | ﹤0.01% | 2669 |
|
|
2023
Q3 | $11.6K | Sell |
124
-41
| -25% | -$3.84K | ﹤0.01% | 2733 |
|
|
2023
Q2 | $14.7K | Sell |
165
-40
| -20% | -$3.48K | ﹤0.01% | 2736 |
|
|
2023
Q1 | $22K | Buy |
+205
| New | +$23.5K | ﹤0.01% | 2738 |
|
|
2022
Q3 | – | Sell |
-4,093
| Closed | -$380K | – | 2906 |
|
|
2022
Q2 | $380K | Hold |
4,093
| – | – | ﹤0.01% | 1394 |
|
|
2022
Q1 | $480K | Hold |
4,093
| – | – | ﹤0.01% | 1343 |
|
|
2021
Q4 | $551K | Hold |
4,093
| – | – | ﹤0.01% | 1368 |
|
|
2021
Q3 | $652K | Hold |
4,093
| – | – | ﹤0.01% | 1126 |
|
|
2021
Q2 | $538K | Sell |
4,093
-744
| -15% | -$99.1K | ﹤0.01% | 1192 |
|
|
2021
Q1 | $623K | Hold |
4,837
| – | – | ﹤0.01% | 1087 |
|
|
2020
Q4 | $807K | Buy |
4,837
+785
| +19% | +$130K | ﹤0.01% | 1044 |
|
|
2020
Q3 | $625K | Hold |
4,052
| – | – | ﹤0.01% | 992 |
|
|
2020
Q2 | $599K | Buy |
4,052
+1,267
| +45% | +$174K | 0.01% | 945 |
|
|
2020
Q1 | $314K | Hold |
2,785
| – | – | ﹤0.01% | 1020 |
|
|
2019
Q4 | $387K | Buy |
+2,785
| New | +$309K | ﹤0.01% | 995 |
|
Other funds holding ASND
RCM
ACA
